Semin Vasc Med 2003; 03(1): 025-032
DOI: 10.1055/s-2003-38330
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Venous and Arterial Thrombosis during Pregnancy: Epidemiology

Isobel D. Walker
  • Department of Haematology, Glasgow, UK
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. März 2003 (online)

ABSTRACT

Venous thromboembolism is an important cause of maternal morbidity and mortality throughout the developed world with an incidence of about 1 per 1000 deliveries, of which 1-2% are fatal. Two thirds of women who have a pregnancy-associated deep vein thrombosis develop the post-thrombotic syndrome and suffer long-term morbidity. The risk of venous thromboembolism is greater in older women and in women who have an operative delivery. Other risk factors include obesity, high parity, and immobilization. Acquired or inherited thrombophilias augment the risk, and some women with a previous history of venous thromboembolism may be at increased risk of a recurrence associated with pregnancy. Arterial thrombosis is uncommon in pregnancy but may have devastating consequences. The incidence of ischemic stroke associated with pregnancy is unknown but is estimated to be about 0.18 per 1000 deliveries-the majority being the result of arterial occlusion. Myocardial infarction is estimated to occur in 0.1 per 1000 women in association with pregnancy. Events occur most frequently peripartum or postpartum. Risk factors include maternal age, atherosclerosis, obesity, hypertension, and smoking.

REFERENCES

  • 1 Confidential Enquiries into Maternal Deaths. Why Mothers Die: Report on Confidential Enquiries into Maternal Deaths 1994-1996. London: The Stationery Office 1998
  • 2 Berg C J, Atrash H K, Koonin L M. et al . Pregnancy related mortality in the United States 1987-1990.  Obstet Gynecol . 1996;  88 161-167
  • 3 Hogberg U, Sandstrom A. Maternal mortality in Sweden, 1980-1988.  Obstet Gynecol . 1994;  84 240-245
  • 4 Sachs B P, Brown D A, Driscoll S G. et al . Mortality in Massachusetts. Trends and prevention.  N Engl J Med . 1987;  316 667-672
  • 5 Hull R D, Raskob G F, Carter C J. Serial IPG in pregnancy patients with clinically suspected DVT. Clinical validity of negative findings.  Ann Intern Med . 1990;  112 663-667
  • 6 Hull R D, Hirsh J, Carter C. et al . Diagnostic efficacy of IPG for clinically suspected DVT: a randomised trial.  Ann Intern Med . 1985;  102 21-28
  • 7 Hull R D, Hirsh J, Sackett D. et al . Diagnostic efficacy of IPG in suspected venous thrombosis: an alternative to venography.  N Engl J Med . 1977;  296 1497-1500
  • 8 Lensing A WA, Prandoni P, Brandjes D. et al . Detection of DVT by real-time B-mode ultrasonography.  N Engl J Med . 1989;  320 342-345
  • 9 Ginsberg J S, Kearon C, Douketis J. et al . D dimer and impedance plethysmography in patients with suspected deep vein thrombosis: results of a management trial.  Arch Intern Med . 1997;  157 1077-1081
  • 10 Ginsberg J S, Greer I A, Hirsh J. Use of antithrombotic agents during pregnancy.  Chest . 2001;  119 122S-131S
  • 11 PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).  JAMA . 1990;  263 2753-2759
  • 12 Hull R D, Hirsh J, Carter C. et al . Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.  Chest . 1985;  88 819-828
  • 13 Letsky E A, de Swiet M. Thromboembolism in pregnancy and its management.  Br J Haematol . 1984;  57 543-552
  • 14 Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study.  Obstet Gynecol . 1999;  94 959-999
  • 15 James K, Lohr J, Deshmukh R. et al . Venous thrombotic complications of pregnancy.  Cardiovasc Surg . 1996;  4 777-782
  • 16 Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy.  Acta Obstet Gynecol Scand . 1983;  62 239-243
  • 17 McColl M D, Ramsay J E, Tait R C, et al.. Risk factors for pregnancy associated venous thromboembolism.  Thromb Haemost . 1997;  78 1183-1188
  • 18 McColl M D, Ramsay J E, Tait R C. et al . Superficial vein thrombosis incidence in association with pregnancy and prevalence of thrombophilic abnormalities.  Thromb Haemost . 1998;  79 741-742
  • 19 Rutherford S, Montoro M, McGahe E W. et al . Thromboembolic disease associated with pregnancy: an 11 year review (Abst).  Am J Obstet Gynecol . 1991;  164(Suppl) S286
  • 20 Macklon N S, Greer I A. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience.  Scot Med J . 1996;  41 83-86
  • 21 Lindhagen A, Bergqvist A, Bergqvist D. et al . Late venous function in the leg after deep vein thrombosis occurring in relation to pregnancy.  Br J Obstet Gynaecol . 1986;  93 348-352
  • 22 Greer I A. Thrombosis in pregnancy: maternal and fetal issues.  Lancet . 1999;  353 1258-1265
  • 23 Lao T T, de Swiet M, Letsky E. et al . Prophylaxis of thromboembolism in pregnancy: an alternative.  Br J Obstet Gynaecol . 1985;  92 202-206
  • 24 Badaracco M, Vessey M. Recurrence of venous thromboembolic disease and use of oral contraceptive.  Br Med J . 1974;  1 215-217
  • 25 Brill-Edwards P, Ginsberg J S, Gent M. et al . Safety of withholding heparin in pregnant women with a history of venous thromboembolism.  N Engl J Med . 2000;  343 1439-1444
  • 26 Simioni P, Tormene D, Prandoni P. et al . Pregnancy related recurrent events in thrombophilic women with a previous venous thromboembolism [letter].  Thromb Haemost . 2001;  86 929
  • 27 McColl M D, Ellison J, Greer I A. et al . Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism.  Br J Haematol . 2000;  108 272-274
  • 28 McFaul P B, Dornan J C, Lamki H. et al . Pregnancy complicated by maternal heart disease. A review of 519 women.  Br J Obstet Gynaecol . 1988;  95 861-867
  • 29 Cannegieter S, Rosendaal F R, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.  Circulation . 1994;  89 635-641
  • 30 Hanania G, Thomas D, Michel P L. et al . Pregnancy and prosthetic heart valves; a French co-operative retrospective study of 155 cases.  Eur Heart J . 1994;  15 1651-1658
  • 31 Chan W S, Anand S, Ginsberg J S. Anticoagulation of pregnant women with mechanical heart valves.  Arch Intern Med . 2000;  160 191-196
  • 32 Sullivan J M, Ramanathan K B. Management of medical problems in pregnancy-severe cardiac disease.  N Engl J Med . 1985;  313 304-309
  • 33 Hankins G D, Wendel G D, Leveno K J. et al . Myocardial infarction during pregnancy. A review.  Obstet Gynecol . 1985;  65 139-146
  • 34 Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy.  Ann Intern Med . 1996;  125 751-762
  • 35 Liao J, Cockrill B, Yurchak P. Acute myocardial infarction after ergonovine administration for uterine bleeding.  Am J Cardiol . 1991;  68 823-824
  • 36 Taylor G B, Cohen B. Ergonovine induced coronary artery spasm and myocardial infarction after normal delivery.  Obstet Gynecol . 1985;  66 821-822
  • 37 Pettiti D B, Sidney S, Quesenberry C P. et al . Incidence of stroke and myocardial infarction in women of reproductive age.  Stroke . 1997;  28 280-283
  • 38 Jaigobin C, Silver F. Stroke and pregnancy.  Stroke . 2000;  31 2948-2951
  • 39 Kittner S J, Stern B J, Feeser B R. et al . Pregnancy and the risk of stroke.  N Engl J Med . 1996;  335 768-774
  • 40 Cross J, Castro P, Jennett W B. Cerebral strokes associated with pregnancy and the puerperium.  Br Med J . 1968;  3 214-218
  • 41 Simolke G A, Cox S M, Cunningham F G. Cerebrovascular accidents complicating pregnancy and the puerperium.  Obstet Gynecol . 1991;  78 37-42
  • 42 Hagen P T, Scholz D G, Edwards W D. Incidence and size of patent foramen ovale during the first 10 decades of life; an autopsy study of 965 normal hearts.  Mayo Clinic Proc . 1984;  59 17-20
  • 43 Clark P, Brennand J, Conkie J A. et al . Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy.  Thromb Haemost . 1998;  79 1166-1170
  • 44 Kutteh W H. Antiphospholipid antibodies and reproduction.  J Reprod Immunol . 1997;  35 151-171
  • 45 Branch D W, Silver R M, Blackwell J L. et al . Outcome of treated pregnancies with antiphospholipid syndrome. An update of the Utah experience.  Obstet Gynecol . 1992;  80 614-620
  • 46 Thorp J M, Chescheir N C, Fann B. Postpartum myocardial infarction in a patient with antiphospholipid syndrome.  Am J Perinatol . 1994;  11 1-3
  • 47 Conard J, Horellou M H, van Dreden P. et al . Thrombosis and pregnancy in congenital deficiencies in antithrombin III, protein C or protein S: study of 78 women.  Thromb Haemost . 1990;  63 319-320
  • 48 Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors.  Arterioscler Thromb Vasc Biol . 1996;  16 742-748
  • 49 Hellgren M, Svensson P, Dahlback B. Resistance to activated protein C is a basis for venous thromboembolism associated with pregnancy and oral contraceptives.  Am J Obstet Gynecol . 1995;  173 210-213
  • 50 Hollander J E, Hoffmann R S, Gennis P, et al., Prospective multicenter evaluation of cocaine-associated chest p ain. <~>Cocaine Associated Chest Pain (COCHPA) Study Group.  Acad Emerg Med . 1994;  1 330-339
  • 51 Liu S, Forrester R M, Murphy G S. et al . Anaesthetic management of a parturient with myocardial infarction related to cocaine use.  Can J Anaesth . 1992;  39 858-861
  • 52 Livingston J, Mabie B, Ramanathan J. Crack cocaine, myocardial infarction, and troponin I levels at the time of caesarean delivery.  Anesth Analg . 2000;  91 913-915
  • 53 Foster K, Lader D, Cheeseborough S. Infant Feeding Survey 1995. London: The Stationery Office 1997
  • 54 Prescott-Clarke P, Primatesta P. Health Survey for England 1996. London: The Stationery Office 1998
  • 55 NHS Maternity Statistics, England: 1989-1990 and 1994-1995. Department of Health Statistical Bulletin, December 1997.